227711 - NHS: Drugs (Answered)

Nick de Bois
To ask the Secretary of State for Health, what assessment he has made of the level of waste of unused drugs in the NHS; and if he will make a statement.

George Freeman

Information is not held centrally on the annual cost or amount of unused or unnecessary medicines in the National Health Service.

227609 - Cancer: Drugs (Answered)

Nic Dakin
To ask the Secretary of State for Health, what plans he has to ensure that there is adequate future funding of drugs for people with rare and less common cancers.

George Freeman

Better access to the very latest clinically effective medicines for rarer cancers is a priority, which is why we announced a £160 million boost to the Cancer Drugs Fund at the end of August 2014.

227008 - NHS: Research (Answered)

Henry Smith
To ask the Secretary of State for Health, pursuant to the Answer of 24 February 2015 to Question 223768, when NHS England plans to publish its revised approach to promoting and taking account of research in the new healthcare system; and what plans NHS England has to hold a formal consultation on that revised approach.

George Freeman

227007 - NHS: Research (Answered)

Henry Smith
To ask the Secretary of State for Health, pursuant to the Answer of 24 February 2015 to Question 223768, on which dates since 24 November 2014 he has discussed with NHS England its revised approach to promoting and taking account of research in the new healthcare system; and what the content of those discussions was.

George Freeman

226914 - National Institute for Health and Care Excellence (Answered)

Paul Burstow
To ask the Secretary of State for Health, pursuant to the Answer of 2 March 2015 to Question 224947, for what reasons the data requested is aggregated over the three years 2012-14; and if he will provide the figures for (a) 2012, (b) 2013 and (c) 2014 separately.

George Freeman

I regret that the information in my answer of 2 March 2015 was not provided in the format requested. I apologise for this oversight.

The information is shown in the table1.

2012

227321 - Cancer: Drugs (Answered)

Andrew Percy
To ask the Secretary of State for Health, what timescales his Department has set for making decisions on appeals on the delisting of treatments from the Cancer Drugs Fund.

George Freeman

NHS England has advised that decisions on appeals against the removal of drugs from the national Cancer Drugs Fund (CDF) list have now been made and the individual companies concerned have been informed of the outcomes.

A revised national CDF list was published on 12 March 2015 and is available at:

227327 - Hepatitis: Drugs (Answered)

Chloe Smith
To ask the Secretary of State for Health, when NHS England will conclude its preparations for making new hepatitis C drugs available for treating people with cirrhosis of the liver.

George Freeman

NHS England has advised that it is considering extending the current interim commissioning policy for Sofosbuvir plus ledipasvir (Harvoni) and another direct acting antiviral combination therapy for selected patients with cirrhosis associated with Hepatitis C.

227373 - Cancer: Drugs (Answered)

Andrew Percy
To ask the Secretary of State for Health, what assessment he has made of the progress made by the Cancer Drugs Fund Short Life Working Group to date.

George Freeman

NHS England has advised that the Cancer Drugs Fund Working Party has been discussing potential ways for reforming and strengthening the way cancer drugs are evaluated and commissioned in the future. Proposals are very much in their early stages of development.

227140 - Parliamentary and Health Service Ombudsman (Answered)

Alistair Burt
To ask the Secretary of State for Health, what the average time was for the Parliamentary and Health Service Ombudsman to allocate an assessor to a health case in (a) February 2015, (b) August 2014, (c) February 2014 and (d) 2010.

George Freeman

Pages